Atlas Trials

Vincristine and Irinotecan With or Without Temozolomide in Children and Adults With Refractory/Relapsed Rhabdomyosarcoma

Clinical trial NCT01355445 · COMPLETED

Trial details

NCT number
NCT01355445
Sponsor
Centre Oscar Lambret
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
RHABDOMYOSARCOMA
Start date
2012-01-01
Primary completion
2018-06-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.